although the introduction of amphotericin b has greatly improved the prognosis of patients with cryptococcal meningitis , 30 years of experience have revealed important clinical limitations , including modest efficacy , nephrotoxicity , other clinically significant toxicities , and the inconvenience of intravenous dosing .
C0002679
amphotericin b
C0085436
cryptococcal meningitis